Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added (123)I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity

PURPOSE: We hypothesized that assessment of myocardial sympathetic activity with no-carrier-added (nca) (123)I-meta-iodobenzylguanidine (MIBG) compared to carrier-added (ca) (123)I-MIBG would lead to an improvement of clinical performance without major differences in radiation dosimetry. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Verberne, Hein J., Busemann Sokole, Ellinor, van Moerkerken, Astrid F., Deeterink, Joop H. W. M., Ensing, Geert, Stabin, Michael G., Somsen, G. Aernout, van Eck-Smit, Berthe L. F.
Formato: Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668584/
https://www.ncbi.nlm.nih.gov/pubmed/18183394
http://dx.doi.org/10.1007/s00259-007-0668-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668584/
https://www.ncbi.nlm.nih.gov/pubmed/18183394
http://dx.doi.org/10.1007/s00259-007-0668-y

Ejemplares similares